Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 982.00
Bid: 979.00
Ask: 985.00
Change: 4.00 (0.41%)
Spread: 6.00 (0.613%)
Open: 997.00
High: 997.00
Low: 980.00
Prev. Close: 978.00
CVSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Response to CMA review into veterinary market

7 Sep 2023 10:50

RNS Number : 7397L
CVS Group plc
07 September 2023
 

7 September 2023

 

CVS Group plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

 

 

Response to CMA review into the veterinary services market

 

CVS, the UK quoted veterinary group and a leading provider of integrated veterinary services, notes that the Competition and Markets Authority ("CMA") has launched a review into the UK veterinary services market for household pets. We always work closely with our regulators and we and our colleagues will support the CMA review.

 

Our purpose at CVS is to give the best possible care to animals and we continually invest in our colleagues, practices and clinical equipment to enhance the care to our clients and their patients. The Group has always sought to ensure its prices are appropriate and reflect fair value to our clients. Our pricing structures are set by clinicians to ensure these align with our purpose.

 

As the CMA have recognised, there continues to be a significant shortage of vets in the UK and employment costs represent the most significant proportion of our cost base. Our pricing reflects this and other inflationary pressures experienced in recent years.

 

We have a clear strategy to continue to expand our network and to improve clinical care through investment in facilities, equipment, technology and our people.

 

We will announce our full year results on 21 September 2023.

 

 

 

CVS Group plc via Camarco

Richard Fairman, CEO

Ben Jacklin, Deputy CEO

Robin Alfonso, CFO

 

Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418 8900

Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose

 

Berenberg (Joint Broker) +44 (0)20 3207 7800

Toby Flaux / Ben Wright / James Thompson / Milo Bonser

 

Camarco (Financial PR) cvsg@camarco.co.uk

Geoffrey Pelham-Lane +44 (0)7733 124 226

Ginny Pulbrook +44 (0)7961 315 138

Rosie Driscoll +44 (0)7752 245 008

 

 

 

 

About CVS Group plc (www.cvsukltd.co.uk)

CVS Group is an AIM-quoted fully-integrated provider of veterinary services in the UK, with practices in Australia, the Netherlands and the Republic of Ireland. CVS is focused on providing high quality clinical services to its customers and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group has c.500 veterinary practices across its four markets, including nine specialist referral hospitals and 39 dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties), Crematoria (providing pet cremation and clinical waste disposal for CVS and third-party practices), Buying Groups and the Group's online retail business ("Animed Direct").

The Group employs c.8,700 personnel, including c.2,250 veterinary surgeons and c.3,200 nurses.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUPURCBUPWUBM
Date   Source Headline
3rd Jul 20173:17 pmRNSExercise of Options & TVR
30th Jun 20173:59 pmRNSHolding(s) in Company
30th Jun 20172:57 pmRNSExercise of Options & TVR
2nd Jun 201711:38 amRNSHolding(s) in Company
26th May 20171:43 pmRNSHolding(s) in Company
25th May 20175:33 pmRNSExercise of Options & Total Voting Rights
24th May 20172:12 pmRNSHolding(s) in Company
16th May 20171:52 pmRNSHolding(s) in Company
3rd May 20173:44 pmRNSHolding(s) in Company
2nd May 20172:04 pmRNSExercise of Options and Total Voting Rights
26th Apr 20173:32 pmRNSHolding(s) in Company
3rd Apr 20172:40 pmRNSHolding(s) in Company
31st Mar 201711:55 amRNSDirector/PDMR Dealing
31st Mar 20177:00 amRNSInterim Results
15th Mar 20171:39 pmRNSExercise of Options & TVR - Replacement
14th Mar 20175:29 pmRNSExercise of Options & TVR
13th Mar 20174:07 pmRNSHolding(s) in Company
10th Mar 20172:11 pmRNSHolding(s) in Company
8th Mar 20173:31 pmRNSHolding(s) in Company
3rd Mar 20172:37 pmRNSHolding(s) in Company
28th Feb 201710:30 amRNSPurchase of Shares by Employee Benefit Trust
27th Feb 20174:07 pmRNSExercise of Options & TVR
22nd Feb 20173:13 pmRNSHolding(s) in Company
6th Feb 20175:25 pmRNSExercise of Options & Total Voting Rights
27th Jan 201711:27 amRNSExercise of Options, Director/PCA Dealing & TVR
9th Jan 20179:01 amRNSExercise of Options and Total Voting Rights
19th Dec 20164:48 pmRNSHolding(s) in Company
19th Dec 201612:27 pmRNSHolding(s) in Company
19th Dec 201612:15 pmRNSBlock Admission
14th Dec 20161:01 pmRNSResult of Successful £30.2 million Placing & TVR
13th Dec 201610:32 amRNSClose of Accelerated Bookbuild
13th Dec 20167:00 amRNSProposed Accelerated Bookbuild
6th Dec 20161:07 pmRNSHolding(s) in Company
1st Dec 20165:02 pmRNSHolding(s) in Company
29th Nov 201610:05 amRNSHolding(s) in Company
24th Nov 201611:46 amRNSResult of AGM
24th Nov 20167:00 amRNSAGM Statement
15th Nov 20164:36 pmRNSDirector/PDMR and PCA Shareholding
3rd Nov 20169:49 amRNSPosting of Annual Report and Notice of AGM
31st Oct 201610:23 amRNSDirector/PDMR Shareholding
27th Oct 20164:14 pmRNSHolding(s) in Company
26th Oct 20168:50 amRNSExercise of Options, Directors' Dealing and TVR
25th Oct 20163:30 pmRNSDirector/PDMR Shareholding
25th Oct 20162:41 pmRNSHolding(s) in Company
14th Oct 20165:13 pmRNSHolding(s) in Company
12th Oct 20165:13 pmRNSHolding(s) in Company
12th Oct 201611:40 amRNSExercise of Options and Total Voting Rights
11th Oct 20164:37 pmRNSHolding(s) in Company
6th Oct 20163:10 pmRNSHolding(s) in Company
5th Oct 20164:26 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.